My watch list
my.bionity.com  
Login  

Cancer Biomarkers

News Cancer Biomarkers

  • Using algorithms to track down cancer

    Modern medicine is looking for markers that provide early warning of complex diseases. In its quest to discover these “biomarkers”, the ETH spinoff Scailyte has developed software capable of analysing millions of single cells very efficiently. The search for biomarkers is currently one of the bigges more

  • More precise diagnostics for improved cancer outcomes

    An important factor in fighting cancer is the speed at which the disease can be identified, diagnosed and treated. The current standard involves a patient feeling ill or a physician seeing signs of a tumor. These indicators lead to more precise diagnoses via blood tests, x-rays or MRI imaging. But o more

  • NMR technique offers 'molecular window' into living organisms

    A novel technique developed by University of Toronto Scarborough researchers can for the first time get a high-resolution profile of which molecules are present inside a living organism. "In a way we've developed this molecular window that can look inside a living system and extract a full metabolic more

All news on cancer biomarkers

Publications Cancer Biomarkers

  • Clinical utility of circulating non-coding RNAs — an update

    Over the past decade, the amount of research and the number of publications on associations between circulating small and long non-coding RNAs (ncRNAs) and cancer have grown exponentially. Particular focus has been placed on the development of diagnostic and prognostic biomarkers to enable efficient more

  • Analysis of DNA methylation in cancer: location revisited

    Changes in DNA methylation in cancer have been heralded as promising targets for the development of powerful diagnostic, prognostic, and predictive biomarkers. Despite the existence of more than 14,000 scientific publications describing DNA methylation-based biomarkers and their clinical association more

  • Prostate cancer diagnosis and characterization with mass spectrometry imaging

    Prostate cancer (PCa), the most common cancer and second leading cause of cancer death in American men, presents the clinical challenge of distinguishing between indolent and aggressive tumors for proper treatment. PCa presents significant alterations in metabolic pathways that can potentially be me more

All publications on cancer biomarkers
Related topics

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE